Porkodi Panneerselvam

About Porkodi Panneerselvam

I am a dynamic leader with 9+ years of experience translating cutting-edge science into viable, scalable, and compliant oncology therapies. My expertise spans the full development lifecycle, from discovery through to first-in-human (FIH) clinical studies. I have built strong relationships with oncologists, investigators and KOLs.My strength is connecting deep science with operational execution and sound business strategy to accelerate program delivery.What I deliver:Technical leadership: Clinical readiness and Target Product Profile (TPP) validation of CAR-T, TCR-T, Vaccines, Monoclonal antibodies and Bispecific antibodies. Deep experience with translational biomarker strategy for oncology assets.Program Leadership: Steering complex programs by leading cross-functional teams (Process & Analytical Development, Quality, Regulatory, Clinical, and Medical). Scientific bridge between research teams and the field teams.Strategic Insight: Informing brand strategy, market readiness, and portfolio decisions, integrating deep scientific expertise with critical business acumen.Operational Excellence: Managing multimillion-dollar budgets, overseeing regulatory engagement, and streamlining development pipelines for greater efficiency and growth.Partnership & Growth: Search & Evaluation, Leading due diligence for key collaborations and ensuring therapies are manufacturable and compliant for market success. KOL Engagement.I am seeking opportunities to leverage my scientific expertise and strategic leadership to guide organizational strategy and optimize therapeutic portfolios for maximum patient impact.Looking ahead, I am eager to bring my background in scientific evaluation and external innovation to business and corporate development roles, where I can strengthen partnerships, shape portfolio strategy, and drive value creation across the R&D to market continuum.CORE EXPERTISEAntibody based Immunotherapies for Oncology | Adoptive cell therapies - CAR-T/TCR-T | Cancer vaccines - Shared & Personalized | Cross functional program leadership | Lead validation and Characterization | Clinical Protocols | Clinical biomarker strategy | Clinical translation | Leadership and mentorship of scientific teams | Executive-Level communication | Strategic Partnership & Alliance management | Search and Evaluation | Competitive intelligence | Due diligence | Corporate strategy | Regulatory engagement | Budget oversight | Market Landscaping & Positioning | KOL and Stakeholder engagement

Experience

1. Associate Director

   BioNTech SE

   Jul 2022 — Present · Gaithersburg, MD, US

   Spearheaded the development and translation of novel cell and gene therapy product concepts, advancing candidates from early-stage research into clinical readiness - determining unmet needs, assessing market insights and identifying differentiation from competitors Directed process development and scale-up of cell engineering platforms supporting both conventional and rapid manufacturing approaches for clinical translation. BD activities - Search and Evaluation, Competitive Intelligence, Partnership/Collaboration engagementRecipient of BioNTech US “Sonia Ting Award for Employee Excellence,” (2022) for outstanding performance and leadership

Education

• FAES Graduate school at NIH

  Advanced studies in Technology Transfer

  2015 — 2018

• Singapore MIT Alliance, National University of Singapore and Massachusetts Institute of Technology

  Doctor of Philosophy (PhD), Cellular and Molecular Immunology

  2007 — 2012

• Anna University Chennai

  Bachelor of Technology (B.Tech.), Industrial Biotechnology

  2003 — 2007

Skills

• Biochemistry
• Western Blotting
• Confocal Microscopy
• Flow Cytometry
• Polymerase Chain Reaction (Pcr)
• Infection
• Virology
• Immunology
• Cell Sorting
• Cell Culture
• Molecular Cloning
• Molecular Biology
• Matlab
• Science
• Research
• Pcr
• Microsoft Office
• Animal Handling
• Cell Biology
• Electron Microscopy
• Business Analysis
• In Vivo
• Analysis
• Molecular & Cellular Biology
• Transduction
• Cell
• In Vitro